SGRT in Head and Neck Cancer Radiotherapy

This study is a prospective, randomized, open-label, single-center exploratory trial. A total of 40 newly diagnosed, untreated head and neck cancer patients （stage I-IVa, AJCC 8th edition） will be enrolled and randomly assigned in a 1：1 ratio to either the experimental group or the control group. The experimental group will receive radiotherapy immobilization using optical surface guidance technology combined with an open-face mask, while the control group will undergo conventional positioning with a closed head-neck-shoulder thermoplastic mask. The primary objective is to compare the six-dime

Trial Details

NCT ID
NCT07726407
Phase
NA
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • SGRT-guided radiotherapy with open thermoplastic mask immobilization
  • Closed head-neck-shoulder thermoplastic mask with laser alignment
Locations (sample)
  • Guangzhou, Guangdong, China|23.11667,113.25

Key Eligibility Criteria

  • Age ≥ 18 years, \<75 years.
  • Histologically or cytologically confirmed head and neck malignant tumors （including nasopharynx, oropharynx, larynx, hypopharynx, oral cavity, etc.）.
  • Stage T1-4, N0-3, M0 （Stage I-IVa） according to AJCC 8th edition.
  • Planned to receive radical radiotherapy （with or without concurrent chemotherapy/ targeted therapy）.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →